BIO-Europe Spring
Mar. 8, 2010-Mar. 10, 2010Centre Convenciones Internacional Barcelona
Barcelona, Spain
www.ebdgroup.com/bes
Description:
Next Wave: Partnering and Financing Opportunities for Assets that Survived the Shake-out
Ben Bonifant, Vice President and head of our Business Development practice, will moderate a panel discussion covering emerging areas of financing and partnering opportunities. Panelists will include executives from Merck Serono, Ironwood Pharmaceuticals, Advent Healthcare Ventures, and Yorkville Advisors.
Abstract:
Next Wave: Partnering and Financing Opportunities for Assets that Survived the Shake-out
Many battle-lines have been drawn by large pharmaceutical companies and investors in the tight financing environment over the past year. Assets with definitive value stories in “hot” therapeutic areas such as oncology, CNS, and metabolics floated to the top. Many of these programs benefited during the surprisingly strong increase in licensing activity during the fourth quarter of 2009. So, in what areas do the next wave of partnering and financing opportunities exist? Over the past year, large pharmaceutical companies and investors have gravitated toward licensing and funding assets in a fairly narrow group of categories. This may be leaving some valuable opportunities for companies willing to partner with or invest in assets in other areas.
We have identified three areas that were not the focus of recent dealmaking, but with a moderate level of investment could yield a disproportionate increase in value:
- Early stage programs outside of the “hot” therapeutic areas
- Promising assets that require additional investment before embarking on an expensive phase 3 program
- And, pre-launch products about to enter challenging or highly competitive specialty or primary care markets
Join our panel of experts as they look more closely at the types of assets that fall into these areas and discuss what alternative partnering and financing options are available for the emerging companies hoping to commercialize them.
Moderator:
Ben Bonifant, VP, Business Development Practice, Campbell Alliance
Panelists:
Christoph Hüls – VP, Early Stage Licensing, Merck Serono
Tom Needham – Partner, Advent Healthcare Ventures
Michael J. Nowak, PhD – Managing Director, Yorkville Advisors, LLC
James O’Mara – VP, Business Development, Ironwood
Feature Articles
George Schmidt, Senior Vice President of the Sales Practice, discusses the impact of the current pharma and biotech landscape on sales forces and Training & Development departments....
Don't Miss
Campbell Alliance will exhibit at this event. Please visit us at booth # 5240. Also at the event, the Business Development Practice will be participating in partnering meetings in the Business Forum.
Webster Sun, Senior Practice Executive, Brand Management Practice, will moderate a panel discussion on the opportunities and challenges surrounding generic versions of many blockbuster biopharmaceutical products following their patent expiration.
Emily Hua, Vice President, Brand Management Practice, will moderate a panel discussion on first-to-market strategies and key lessons learned.
Kevin Barnett, Senior Vice President and Head of the Managed Markets Practice, Campbell Alliance and the Pharmaceutical Institute will participate in a panel discussion on health care reform and the potential implications for the life science industry.
George Schmidt, Senior Vice President, and John Bye, Vice President ,Sales Practice, will lead workshops on staying strategic in today's environment, driving sales force effectiveness and building sustainable training programs.
Campbell Alliance's Trade and Distribution Practice will exhibit at this event. Please visit us at booth #420.
Darius Naigamwalla, Senior Vice President and Global Practice Area Lead, and Tom Luginbill, Vice President, Brand Management Practice, lead a workshop on best practices for commercial planning and the requirements at each stage of the development process.
Keith Morris, Practice Executive, will present a session on successful communication strategies for effective execution of post-approval studies.
Joe Dillon, Senior Practice Executive, Campbell Alliance, will lead a discussion on maximizing the value of product candidates and technologies through a structured deal approach.
Kevin Barnett, Senior Vice President and Practice Area Lead, Managed Markets Practice will serve as chairman for the conference, as well as present a session on how to avoid common mistakes when contracting with payers.
Barrett Rankin, Practice Executive, Business Development Practice, will present a session on linking portfolio management with business development.
Executives from our Brand Management and Managed Markets Practice will have leadership roles at this event.
Kevin Barnett, Senior Vice President and Practice Area Lead, Managed Markets Practice, will present a session on developing and communicating a payer value proposition.
Campbell Alliance's Managed Markets Practice will exhibit at this event.
Campbell Alliance's Trade and Distribution Practice will exhibit at this event.
Executives from our Business Development Practice will moderate two panel discussions at this event.
Leaders from the Brand Management Practice will present a pre-conference workshop on strategies and best practices for managing the logistics of launch, while leaders from the Managed Markets Practice will present a health policy outlook for 2010.
Tony Lanzone, Vice President and head of the Trade and Distribution Practice at Campbell Alliance, will serve as conference chairman, while Jay Jauregui, also of the Trade and Distribution Practice, will present on developing a specialty distribution strategy.
Keith Kelly, Senior Practice Executive, Managed Markets Practice, will present a session on developing a managed care marketing strategy
Campbell Alliance is a sponsor of this event and executives within the Brand Management and Clinical Development Practices will attend.
Darius Naigamwalla, Senior Vice President and Global Practice Area Leader, Brand Management Practice, will present a session on systematically building commercial innovation into oncology launch plans. Also, Tony Lanzone, Vice President, Managed Markets Practice, will present a session on the evolving pricing, reimbursement, and access environment for oncology products.
Gary Tyson, Senior Vice President, Clinical Development Practice, will present a session on leveraging effective SOPs to create a community of compliance and adherence.
Gary Tyson, Senior Vice President, Clinical Development Practice, will present a session on the key learnings of CTMS implementation derived from the experiences of several organizations that have undergone implementation.
Three executives from our Business Development and Managed Markets Practices will present "Reimbursement: The New Investment Hurdle"
Darius Naigamwalla, Global Practice Area Leader, and Tom Luginbill, Vice President, both of the Brand Management Practice, will present a pre-conference workshop on strategies and best practices for strategically managing an oncology product launch. Also Tony Lanzone, Vice President in the Managed Markets Practice will moderate a payer panel discussion on the evolving pricing, reimbursement, and access environment for oncology products.
Mike Menta, Senior Practice Executive, Clinical Development Practice, will moderate a session on both opportunities and challenges of conducting clinical trials abroad.
Lujing Wang, Vice President, Managed Markets Practice, will present a session on evidence-based medicine in an evolving landscape for global market access.
Gautam Aggarwal, Senior Practice Executive in our Business Development Practice, will present the results and observations from Campbell Alliance's 2010 Dealmakers' Intentions Survey and moderate a panel discussion with leading business development decision makers.
Gautam Aggarwal, Senior Practice Executive, Business Development Practice, will present the results and observations from Campbell Alliance's Dealmaker's Intentions Survey.